La Jolla pharmaceutical
La Jolla Pharmaceutical scores FDA approval for blood pressure treatment
December 22, 2017Medical Communications, Sales and Marketing FDA, La Jolla pharmaceutical, blood pressure, pharma
The FDA has announced that it has approved La Jolla Pharmaceutical’s Giapreza (angiotensin II) injection for intravenous infusion to increase …
La Jolla finds potential jewel in successful Phase 3 trial
February 27, 2017Manufacturing and Production, Research and Development La Jolla pharmaceutical
La Jolla Pharmaceutical, a biotech company based in San Diego, US, received a boost to both its shares and its …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
